The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.

Park, Jun Won; Kim, Min Jung; Kim, Hyoun-Ah; Kim, Jin Hyun; Lee, Eun Bong; Shin, Kichul

Park, Jun Won; Kim, Min Jung; Kim, Hyoun-Ah; Kim, Jin Hyun; Lee, Eun Bong; Shin, Kichul.

Afiliación

Park JW; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Kim MJ; Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul Boramae Medical Center, Seoul, South Korea.
Kim HA; Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea.
Kim JH; Division of Rheumatology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, South Korea.
Lee EB; Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Shin K; Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul Boramae Medical Center, Seoul, South Korea.

Front Med (Lausanne) ; 9: 839206, 2022.

Article en En | MEDLINE | ID: mdl-35211491

Palabras clave

bDMARD therapy; dose tapering; rheumatoid arthritis; tocilizumab; treat-to-target

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google